/People

Jeffrey M. Jonas

Investor

Partner at Cure Ventures

Boston, Massachusetts, United States

Find your path to Jeffrey

Sign up to see every warm intro you have to Jeffrey

  • Paths you didn't know you had: your email and LinkedIn already hold routes to Jeffrey. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

About

Partner with over two decades in R&D leadership and CNS drug discovery, contributing to medicines such as Lexapro, Vyvanse, Zulresso, and Namenda. Formerly CEO of ABIO-X and CEO/Chief Innovation Officer at Sage Therapeutics.

Contact· self-published, not guessed

Colleagues at Cure Ventures

Frequently asked questions

Who is Jeffrey M. Jonas?
Partner with over two decades in R&D leadership and CNS drug discovery, contributing to medicines such as Lexapro, Vyvanse, Zulresso, and Namenda. Formerly CEO of ABIO-X and CEO/Chief Innovation Officer at Sage Therapeutics.
Where does Jeffrey M. Jonas work?
Jeffrey M. Jonas is Partner at Cure Ventures.

Founder mafias

About this profile. Compiled from public sources — Cure Ventures's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights